Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and ?-catenin pathway in AKI-to-CKD continuum.
Ontology highlight
ABSTRACT: Background:Acute kidney injury (AKI) is one of the major risk factors for progression to chronic kidney disease (CKD) and renal fibrosis. However, effective therapies remain poorly understood. Here, we examined the renoprotective effects of melatonin and poricoic acid A (PAA) isolated from the surface layer of Poria cocos, and investigated the effects of combined therapy on the interaction of TGF-?/Smad and Wnt/?-catenin in a rat model of renal ischemia-reperfusion injury (IRI) and hypoxia/reoxygenation (H/R) or TGF-?1-induced HK-2 cells. Methods:Western blot and immunohistochemical staining were used to examine protein expression, while qRT-PCR was used to examine mRNA expression. Coimmunoprecipitation, chromatin immunoprecipitation, RNA interference, and luciferase reporter gene analysis were employed to explore the mechanisms of PAA and melatonin's renoprotective effects. Results:PAA and combined therapy exhibited renoprotective and antifibrotic effects, but the underlying mechanisms were different during AKI-to-CKD continuum. Melatonin suppressed Smad-dependent and Smad-independent pathways, while PAA selectively inhibited Smad3 phosphorylation through distrupting the interactions of Smad3 with TGF?RI and SARA. Further studies demonstrated that the inhibitory effects of melatonin and PAA were partially depended on Smad3, especially PAA. Melatonin and PAA also inhibited the Wnt/?-catenin pathway and its profibrotic downstream targets, and PAA performed better. We further determined that IRI induced a nuclear Smad3/?-catenin complex, while melatonin and PAA disturbed the interaction of Smad3 and ?-catenin, and supplementing with PAA could enhance the inhibitory effects of melatonin on the TGF-?/Smad and Wnt/?-catenin pathways. Conclusions:Combined melatonin and PAA provides a promising therapeutic strategy to treat renal fibrosis during the AKI-to-CKD continuum.
SUBMITTER: Chen DQ
PROVIDER: S-EPMC6696851 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA